Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery DOI Creative Commons
Eman Zmaily Dahmash,

Nour Radwan Achkar,

Dalia Khalil Ali

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Апрель 29, 2024

Abstract Fixed dose combinations (FDCs) incorporating two or three medicines in a single inhaler have been created to enhance patient compliance and hence clinical outcomes. However, the development of dry powder inhalers (DPIs), particularly for FDCs, faces challenges pertinent formulation uniformity reproducibility. Therefore, this project aimed employ nanotechnology develop FDC DPIs market-leading medicines—fluticasone propionate (FP) salmeterol xinafoate (SAL)—for asthma management. Nanoaggregates were prepared using novel biocompatible biodegradable poly(ester amide) based on amino acid tyrosine, utilising one-step interfacial polymerisation process. The produced tyrosine poly (ester drug-loaded nanoparticles evaluated content uniformity, PSA, FTIR, TEM, DSC, XRD aerodynamic performance (in vitro vivo). optimised demonstrated high entrapment efficiency– > 90%. terms emitted dose, fine particle fraction respirable was superior carrier-based marketed product. In-vivo studies showed that FP (above formulation) SAL reached lungs mice reproducible manner. These results highlight superiority FP/SAL via process, which can be used as cost-effective efficient method alleviate burden asthma.

Язык: Английский

Pulmonary inhalation for disease treatment: Basic research and clinical translations DOI Creative Commons
Bin Wang, Lin Wang,

Qian Yang

и другие.

Materials Today Bio, Год журнала: 2024, Номер 25, С. 100966 - 100966

Опубликована: Янв. 22, 2024

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with few systemic side effects. In addition, it is non-invasive good patient compliance, making a highly promising mode. However, there have been limited studies on via pulmonary inhalation compared oral intravenous modes. This paper summarizes basic research clinical translation for treatment diseases provides insights into latest advances in delivery. The discusses processing methods delivery, carriers (with focus various types nanoparticles), devices, applications (e.g., COVID-19, inhaled vaccines, diagnosis diseases, diabetes mellitus) an updated summary recent advances. Furthermore, this describes progress lung expands use drugs other diseases.

Язык: Английский

Процитировано

27

Excipient-free inhalable combination shell-core microparticles with clofazimine shell for extended pulmonary retention of isoniazid in core DOI
Kolimi Prashanth Reddy,

Lakshmi Tulasi Naraharisetti,

Vani Sai Prasanna

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер 672, С. 125310 - 125310

Опубликована: Фев. 8, 2025

Язык: Английский

Процитировано

1

Bacteria-based drug delivery for treating non-oncological diseases DOI
Zhenping Cao, Yan Pang,

Jun Pu

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 366, С. 668 - 683

Опубликована: Янв. 18, 2024

Язык: Английский

Процитировано

9

Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery DOI
David Encinas-Basurto, Basanth Babu Eedara, Heidi M. Mansour

и другие.

Journal of Pharmaceutical Investigation, Год журнала: 2024, Номер 54(2), С. 145 - 160

Опубликована: Фев. 8, 2024

Язык: Английский

Процитировано

6

Supercritical Fluids: An Innovative Strategy for Drug Development DOI Creative Commons
Hui Liu,

Xiaoliu Liang,

Yisheng Peng

и другие.

Bioengineering, Год журнала: 2024, Номер 11(8), С. 788 - 788

Опубликована: Авг. 4, 2024

Nanotechnology plays a pivotal role in the biomedical field, especially synthesis and regulation of drug particle size. Reducing particles to micron or nanometer scale can enhance bioavailability. Supercritical fluid technology, as green development strategy, is expected resolve challenges thermal degradation, uneven size, organic solvent residue faced by traditional methods such milling crystallization. This paper provides an insight into application super-stable homogeneous intermix formulating technology (SHIFT) super-table pure-nanomedicine formulation (SPFT) developed based on supercritical fluids for dispersion micronization. These technologies significantly solubility permeability hydrophobic drugs controlling size morphology, modified show excellent therapeutic efficacy treatment hepatocellular carcinoma, pathological scarring, corneal neovascularization, their performance are highlighted when administered through multiple routes administration. Overall, have opened efficient pathway clinical development, which reduce side effects efficacy.

Язык: Английский

Процитировано

6

Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements DOI Creative Commons
Sabrina Magramane,

Kristina Vlahović,

Peter G. Gordon

и другие.

Pharmaceuticals, Год журнала: 2023, Номер 16(12), С. 1658 - 1658

Опубликована: Ноя. 28, 2023

In this review, an extensive analysis of dry powder inhalers (DPIs) is offered, focusing on their characteristics, formulation, stability, and manufacturing. The advantages pulmonary delivery were investigated, as well the significance particle size in drug deposition. preparation DPI formulations was also comprehensively explored, including physico-chemical characterization powders, processing techniques, formulation considerations. addition to manufacturing procedures, testing methods discussed, providing insights into development evaluation formulations. This review explores design basics critical attributes specific DPIs, highlighting optimization achieve effective inhalation therapy. Additionally, morphology stability 3 capsules (Spiriva, Braltus, Onbrez) offering valuable properties these Altogether, findings contribute a deeper understanding DPIs development, performance, dosage forms.

Язык: Английский

Процитировано

12

Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies DOI
Nazrul Islam, Tan Suwandecha, Teerapol Srichana

и другие.

DARU Journal of Pharmaceutical Sciences, Год журнала: 2024, Номер unknown

Опубликована: Июнь 11, 2024

Язык: Английский

Процитировано

5

Recent advances in dosage form design for the elderly: a review DOI
Sagar Salave,

Pranav Patel,

Nimeet Desai

и другие.

Expert Opinion on Drug Delivery, Год журнала: 2023, Номер 20(11), С. 1553 - 1571

Опубликована: Ноя. 2, 2023

Introduction With the increase in elderly population and prevalence of multiple medical conditions, medication adherence, efficacy have become crucial for effective management their health. The aging faces unique challenges that need to be addressed through advancements drug delivery systems formulation technologies.

Язык: Английский

Процитировано

10

Highly Drug-Loaded Nanoaggregate Microparticles for Pulmonary Delivery of Cyclosporin A DOI Creative Commons
Yongpeng Huang, Hui Tang,

Xiangyan Meng

и другие.

International Journal of Nanomedicine, Год журнала: 2024, Номер Volume 19, С. 7529 - 7546

Опубликована: Июль 1, 2024

Nanoparticles have the advantages of improving solubility poorly water-soluble drugs, facilitating drug across biological barriers, and reducing macrophage phagocytosis in pulmonary delivery. However, nanoparticles a small aerodynamic particle size, which makes it difficult to achieve optimal deposition when delivered directly lungs. Therefore, delivering lungs effectively has become popular research topic.

Язык: Английский

Процитировано

4

Numerical analysis of collision mechanism that causes particle tribocharging in dry powder inhaler DOI Creative Commons
Ryosuke Mitani,

Muhammad Aiman bin Mohd Nor,

Takeshi Iinuma

и другие.

Asian Journal of Atmospheric Environment, Год журнала: 2025, Номер 19(1)

Опубликована: Янв. 22, 2025

Abstract Chronic obstructive pulmonary disease (COPD) is induced by inhalation of toxic substances such as cigarettes and air pollution. Dry powder inhalers (DPIs) are the primary treatment for these diseases. However, they have some problems, residuals in a capsule caused electrostatic force before reaching human lungs. This study investigated particle tribocharging mechanism DPI using tandem differential mobility analyzer (TDMA) combined discrete element method computational fluid dynamics (DEM-CFD) approach. In TDMA experiment, charging state particles changed from negative to positive charge device fabricated 3D printer. because particle–particle collisions particle–wall collisions. numerical simulation, occurred more frequently than Therefore, change device. These results suggest that between walls cause become charged, leading decrease their deposition deeper regions Moreover, large turbulence kinetic energy airflow were widely dispersed optimum necessary reduce aggregation improve delivery efficiency DPIs Graphical

Язык: Английский

Процитировано

0